- Home
- FN vs ICLR Comparison
FN vs ICLR Comparison
Compare FN & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FN
- ICLR
- Stock Information
- Founded
- FN 1999
- ICLR 1990
- Country
- FN Cayman Islands
- ICLR Ireland
- Employees
- FN N/A
- ICLR N/A
- Industry
- FN Telecommunications Equipment
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- FN Utilities
- ICLR Health Care
- Exchange
- FN Nasdaq
- ICLR Nasdaq
- Market Cap
- FN 10.2B
- ICLR 11.6B
- IPO Year
- FN 2010
- ICLR 1998
- Fundamental
- Price
- FN $308.44
- ICLR $187.01
- Analyst Decision
- FN Buy
- ICLR Buy
- Analyst Count
- FN 7
- ICLR 13
- Target Price
- FN $263.00
- ICLR $211.92
- AVG Volume (30 Days)
- FN 487.3K
- ICLR 1.6M
- Earning Date
- FN 08-18-2025
- ICLR 07-23-2025
- Dividend Yield
- FN N/A
- ICLR N/A
- EPS Growth
- FN 18.98
- ICLR 13.11
- EPS
- FN 8.97
- ICLR 9.73
- Revenue
- FN $3,262,896,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- FN $21.19
- ICLR N/A
- Revenue Next Year
- FN $12.79
- ICLR $1.69
- P/E Ratio
- FN $34.44
- ICLR $19.21
- Revenue Growth
- FN 17.14
- ICLR N/A
- 52 Week Low
- FN $148.55
- ICLR $125.10
- 52 Week High
- FN $314.47
- ICLR $338.67
- Technical
- Relative Strength Index (RSI)
- FN 67.09
- ICLR 71.84
- Support Level
- FN $292.56
- ICLR $139.15
- Resistance Level
- FN $314.47
- ICLR $211.00
- Average True Range (ATR)
- FN 8.35
- ICLR 7.52
- MACD
- FN -1.08
- ICLR 4.29
- Stochastic Oscillator
- FN 82.21
- ICLR 66.61
About FN Fabrinet
Fabrinet provides advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.